Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 03 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding new data presentations at The Liver Meeting in Washington, DC. The company will present four abstracts on Saroglitazar Mg, with two awarded the AASLD Presidential Poster Of Distinction. The USFDA and EMA have granted special designations for Saroglitazar Mg related to Primary Biliary Cholangitis.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases